Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47


Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis.

Hendrix AS, Spoonmore TJ, Wilde AD, Putnam NE, Hammer ND, Snyder DJ, Guelcher SA, Skaar EP, Cassat JE.

Antimicrob Agents Chemother. 2016 Sep;60(9):5322-30. doi: 10.1128/AAC.00834-16.


Trends in Infectious Disease Hospitalizations in US Children, 2000 to 2012.

Goto T, Tsugawa Y, Mansbach JM, Camargo CA Jr, Hasegawa K.

Pediatr Infect Dis J. 2016 Jun;35(6):e158-63. doi: 10.1097/INF.0000000000001134.


Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection.

Wilde AD, Snyder DJ, Putnam NE, Valentino MD, Hammer ND, Lonergan ZR, Hinger SA, Aysanoa EE, Blanchard C, Dunman PM, Wasserman GA, Chen J, Shopsin B, Gilmore MS, Skaar EP, Cassat JE.

PLoS Pathog. 2015 Dec 18;11(12):e1005341. doi: 10.1371/journal.ppat.1005341.


Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.

Ericson JE, Popoola VO, Smith PB, Benjamin DK, Fowler VG, Benjamin DK Jr, Clark RH, Milstone AM.

JAMA Pediatr. 2015 Dec;169(12):1105-11. doi: 10.1001/jamapediatrics.2015.2380.


Prevention of Recurrent Staphylococcal Skin Infections.

Creech CB, Al-Zubeidi DN, Fritz SA.

Infect Dis Clin North Am. 2015 Sep;29(3):429-64. doi: 10.1016/j.idc.2015.05.007. Review.


The Mechanism Underlying the Antibacterial Activity of Shikonin against Methicillin-Resistant Staphylococcus aureus.

Lee YS, Lee DY, Kim YB, Lee SW, Cha SW, Park HW, Kim GS, Kwon DY, Lee MH, Han SH.

Evid Based Complement Alternat Med. 2015;2015:520578. doi: 10.1155/2015/520578.


Indole trimers with antibacterial activity against Gram-positive organisms produced using combinatorial biocatalysis.

McClay K, Mehboob S, Yu J, Santarsiero BD, Deng J, Cook JL, Jeong H, Johnson ME, Steffan RJ.

AMB Express. 2015 Dec;5(1):125. doi: 10.1186/s13568-015-0125-4.


Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009.

Kremers HM, Nwojo ME, Ransom JE, Wood-Wentz CM, Melton LJ 3rd, Huddleston PM 3rd.

J Bone Joint Surg Am. 2015 May 20;97(10):837-45. doi: 10.2106/JBJS.N.01350.


Rifampin use and safety in hospitalized infants.

Arnold CJ, Ericson J, Kohman J, Corey KL, Oh M, Onabanjo J, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB, Chu VH; Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee..

Am J Perinatol. 2015 May;32(6):565-70. doi: 10.1055/s-0034-1543955.


Population-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal Insufficiency.

Le J, Vaida F, Nguyen E, Adler-Shohet FC, Romanowski G, Kim J, Vo T, Capparelli EV.

J Pharmacol Clin Toxicol. 2014;2(1):1017-1026.


Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children.

Ragab AR, Al-Mazroua MK, Al-Harony MA.

Infect Dis Ther. 2013 Jun;2(1):37-46. doi: 10.1007/s40121-013-0004-8.


Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation.

Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D.

BMC Pediatr. 2014 Aug 8;14:199. doi: 10.1186/1471-2431-14-199.


Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid.

Flanagan S, Fang E, Muñoz KA, Minassian SL, Prokocimer PG.

Pharmacotherapy. 2014 Sep;34(9):891-900. doi: 10.1002/phar.1458.


Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

Gonzalez D, Melloni C, Yogev R, Poindexter BB, Mendley SR, Delmore P, Sullivan JE, Autmizguine J, Lewandowski A, Harper B, Watt KM, Lewis KC, Capparelli EV, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee..

Clin Pharmacol Ther. 2014 Oct;96(4):429-37. doi: 10.1038/clpt.2014.134.


No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates.

Goldman JL, Harrison CJ, Myers AL, Jackson MA, Selvarangan R.

Pediatr Infect Dis J. 2014 Feb;33(2):216-8. doi: 10.1097/01.inf.0000436281.18687.0c.


Acute MRSA sinusitis with intracranial extension and marginal vancomycin susceptibility.

Kumar PS, Cunnion KM.

Case Rep Pediatr. 2013;2013:153239. doi: 10.1155/2013/153239.


Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children.

Popoola VO, Carroll KC, Ross T, Reich NG, Perl TM, Milstone AM.

Clin Infect Dis. 2013 Nov;57(10):1458-60. doi: 10.1093/cid/cit542.


Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug.

Flanagan SD, Bien PA, Muñoz KA, Minassian SL, Prokocimer PG.

Pharmacotherapy. 2014 Mar;34(3):240-50. doi: 10.1002/phar.1337.


Effects of aggregate and individual antibiotic exposure on vancomycin MICs for Staphylococcus aureus isolates recovered from pediatric patients.

Rose L, Chan S, Hossain J, Di Pentima MC.

J Clin Microbiol. 2013 Sep;51(9):2837-42. doi: 10.1128/JCM.00768-13.

Items per page

Supplemental Content

Support Center